Stay updated with breaking news from Alexandre Loupy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have developed and validated a new race-free, creatinine-based equation for estimating glomerular filtration rate specifically designed for kidney transplant recipients.
User-friendly ChatGPT-like system allows for accurate diagnoses of rejection, using often complicated Banff classification criteria 'with just a few clicks.' Observers hail the work as 'innovative.'
Press release content from Business Wire. The AP news staff was not involved in its creation.
Cibiltech announced today that the first patient has been enrolled in the CIBIL clinical trial "Clinical Impact of the iBox as an early Intervention tool". A prospective randomized controlled trial
Share this article Share this article SOUTH PLAINFIELD, N.J., Jan. 7, 2021 /PRNewswire/ -- Leading global genomics service provider, GENEWIZ, a Brooks Life Sciences Company, announced today that Alexandre Loupy, MD, Ph.D., Professor of Nephrology and Epidemiology at Necker Hospital, Paris, and Director of the Paris Transplant Group at Inserm, France, has been awarded the GENEWIZ Digital Spatial Profiler Grant. Dr. Loupy will be provided digital spatial profiling services on the NanoString Technologies® GeoMx™ platform for his study investigating the spatial immune response during allograft...